Avner Leshem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Avner Leshem has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Eran Elinav
Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel
3 shared publications Adi Livne
Immunology Department, Weizmann Institute of Science, Rehovot, Israel
2 shared publicationsAleksandra A. Kolodziejczyk
Immunology Department, Weizmann Institute of Science, Rehovot, Israel
2 shared publicationsAlexander Brandis
Department of Biological services, Weizmann Institute of Science, Rehovot, Israel
2 shared publicationsAlon Harmelin
Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel
2 shared publicationsAlona Metz
Immunology Department, Weizmann Institute of Science, Rehovot, Israel
2 shared publications
Latest Publications
- 15 March 2022
- Published by Springer Nature in Nature
- Vol. 603 (7903) , E35
Publisher Correction: Gut microbiota modulates weight gain in mice after discontinued smoke exposure
- 15 March 2022
- Published by Springer Nature in Nature
- Vol. 603 (7903) , E35
Publisher Correction: Gut microbiota modulates weight gain in mice after discontinued smoke exposure
- 8 December 2021
- Published by Springer Nature in Nature
- Vol. 600 (7890) , 713-719
Gut microbiota modulates weight gain in mice after discontinued smoke exposure
Cigarette smoking constitutes a leading global cause of morbidity and preventable death1, and most active smokers report a desire or recent attempt to quit2. Smoking-cessation-induced weight gain (SCWG; 4.5 kg reported to be gained on average per 6–12 months, >10 kg year–1 in 13% of those who stopped smoking3) constitutes a major obstacle to smoking abstinence4, even under stable5,6 or restricted7 caloric intake. Here we use a mouse model to demonstrate that smoking and cessation induce a dysbiotic state that is driven by an intestinal influx of cigarette-smoke-related metabolites. Microbiome depletion induced by treatment with antibiotics prevents SCWG. Conversely, fecal microbiome transplantation from mice previously exposed to cigarette smoke into germ-free mice naive to smoke exposure induces excessive weight gain across diets and mouse strains. Metabolically, microbiome-induced SCWG involves a concerted host and microbiome shunting of dietary choline to dimethylglycine driving increased gut energy harvest, coupled with the depletion of a cross-regulated weight-lowering metabolite, N-acetylglycine, and possibly by the effects of other differentially abundant cigarette-smoke-related metabolites. Dimethylglycine and N-acetylglycine may also modulate weight and associated adipose-tissue immunity under non-smoking conditions. Preliminary observations in a small cross-sectional human cohort support these findings, which calls for larger human trials to establish the relevance of this mechanism in active smokers. Collectively, we uncover a microbiome-dependent orchestration of SCWG that may be exploitable to improve smoking-cessation success and to correct metabolic perturbations even in non-smoking settings.
- 8 December 2021
- Published by Springer Nature in Nature
- Vol. 600 (7890) , 713-719
Gut microbiota modulates weight gain in mice after discontinued smoke exposure
Cigarette smoking constitutes a leading global cause of morbidity and preventable death1, and most active smokers report a desire or recent attempt to quit2. Smoking-cessation-induced weight gain (SCWG; 4.5 kg reported to be gained on average per 6–12 months, >10 kg year–1 in 13% of those who stopped smoking3) constitutes a major obstacle to smoking abstinence4, even under stable5,6 or restricted7 caloric intake. Here we use a mouse model to demonstrate that smoking and cessation induce a dysbiotic state that is driven by an intestinal influx of cigarette-smoke-related metabolites. Microbiome depletion induced by treatment with antibiotics prevents SCWG. Conversely, fecal microbiome transplantation from mice previously exposed to cigarette smoke into germ-free mice naive to smoke exposure induces excessive weight gain across diets and mouse strains. Metabolically, microbiome-induced SCWG involves a concerted host and microbiome shunting of dietary choline to dimethylglycine driving increased gut energy harvest, coupled with the depletion of a cross-regulated weight-lowering metabolite, N-acetylglycine, and possibly by the effects of other differentially abundant cigarette-smoke-related metabolites. Dimethylglycine and N-acetylglycine may also modulate weight and associated adipose-tissue immunity under non-smoking conditions. Preliminary observations in a small cross-sectional human cohort support these findings, which calls for larger human trials to establish the relevance of this mechanism in active smokers. Collectively, we uncover a microbiome-dependent orchestration of SCWG that may be exploitable to improve smoking-cessation success and to correct metabolic perturbations even in non-smoking settings.
- 23 June 2021
- Published by Springer Nature in Nature
- Vol. 595 (7865) , 32-34
Designer fibre meals sway human gut microbes
- 23 June 2021
- Published by Springer Nature in Nature
- Vol. 595 (7865) , 32-34
Designer fibre meals sway human gut microbes